Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery

NCT01174719 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Valvular Heart Disease
Coronary Artery Disease

Interventions

DRUG: volume replacement
DRUG: Humanalbumin 5%
DRUG: volume replacement

Sponsor

Medical University of Vienna